Prostate Cancer - Results from #20720

How to optimize patient selection for robot-assisted radical prostatectomy: Functional outcome analyses from a tertiary referral center - Abstract April 24, 2014

Predicting the risk of non-organ-confined prostate cancer when perineural invasion is found on biopsy - Abstract April 24, 2014

A clinical review on extreme hypofractionated stereotactic body radiation therapy for localized prostate cancer using nonrobotic linear accelerators - Abstract April 24, 2014

Active surveillance for low-risk prostate cancer: Diversity of practice across Europe - Abstract April 24, 2014

Prostate-specific antigen measured 3 months after radical prostatectomy as a new predictor of biochemical recurrence - Abstract April 24, 2014

Are active surveillance criteria sufficient for predicting advanced stage prostate cancer patients? - Abstract April 24, 2014

Clinical outcomes of CyberKnife radiotherapy in prostate cancer patients: Short-term, single-center experience - Abstract April 24, 2014

Radical prostatectomy as radical cure of prostate cancer in a high-risk group: A single-institution experience - Abstract April 24, 2014

Relationship between sexual function and prostate-specific antigen bounce after iodine-125 permanent implant brachytherapy for localized prostate cancer - Abstract April 24, 2014

Usefulness of proton magnetic resonance spectroscopy in predicting positive biopsy after high-intensity focused ultrasound for treatment of localized prostate cancer - Abstract April 24, 2014

Clarifying the positive association between education and prostate cancer: A Monte Carlo simulation approach - Abstract April 24, 2014

Reference pricing for proton therapy will help establish clinical benefits, say radiation oncologists from Penn's Roberts Proton Therapy Center April 23, 2014

OPKO announces launch of 4Kscore Test for prostate cancer April 23, 2014

Intensity modulated radiotherapy (IMRT) to prostate and pelvic nodes; is pelvic lymph node coverage adequate with fiducial-based image guided radiotherapy? - Abstract April 23, 2014

Docetaxel based chemotherapy in the treatment of patients with castration resistant prostate cancer - Abstract April 23, 2014

Bilaterally positive biopsy cores are associated with non-organ-confined disease in prostate cancer patients eligible for active surveillance - Abstract April 23, 2014

Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT - Abstract April 22, 2014

The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer - Abstract April 22, 2014

Nonmetastatic castration-resistant prostate cancer - Abstract April 22, 2014

Early experience with active surveillance in low-risk prostate cancer treated - Abstract April 22, 2014

Page 1037 of 1436